Benzinga · Oct 9, 2026
JP Morgan Downgrades DuPont de Nemours to Neutral, Lowers Price Target to $145
JP Morgan analyst Chigusa Katoku downgrades DuPont de Nemours (NYSE:DD) from Overweight to Neutral and lowers the price target from $172 to $145.

NYSE · DD
Basic Materials · Chemicals - Specialty
$131.60
Up+$3.12 (+2.43%)
Updated Oct 16, 2026, 10:04 AM
SID Score
6.9/10
Composite research score
Smart Money
58/100
Neutral
Price performance · DD
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 15, 2026
DD closed at $131.60 after 21 trading sessions, up 2.44% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | $128.91 | $131.64 | $128.20 | $131.60 | 1.33M |
| Oct 14, 2026 | $128.85 | $129.91 | $127.55 | $128.48 | 798.64K |
| Oct 13, 2026 | $130.26 | $130.80 | $129.02 | $129.55 | 753.33K |
| Oct 12, 2026 | $129.59 | $131.21 | $129.16 | $129.37 | 604.9K |
| Oct 9, 2026 | $131.26 | $131.89 | $129.90 | $130.00 | 615.21K |
| Oct 8, 2026 | $129.39 | $132.64 | $129.39 | $132.48 | 816.42K |
| Oct 7, 2026 | $131.54 | $132.56 | $130.44 | $131.08 | 638.33K |
| Oct 6, 2026 | $131.35 | $134.00 | $130.68 | $133.28 | 716.78K |
| Oct 5, 2026 | $131.25 | $131.609 | $129.18 | $130.69 | 700.67K |
| Oct 2, 2026 | $130.74 | $130.86 | $129.14 | $129.98 | 686.01K |
| Oct 1, 2026 | $128.96 | $129.90 | $127.62 | $129.20 | 950.69K |
| Sep 30, 2026 | $130.48 | $131.17 | $129.745 | $129.89 | 778.27K |
| Sep 29, 2026 | $130.97 | $131.21 | $129.59 | $130.12 | 1.02M |
| Sep 28, 2026 | $130.50 | $131.63 | $129.805 | $130.98 | 834.24K |
| Sep 25, 2026 | $130.50 | $132.16 | $129.7301 | $131.71 | 780.53K |
| Sep 24, 2026 | $130.23 | $131.65 | $129.1401 | $130.22 | 809.96K |
| Sep 23, 2026 | $130.83 | $131.89 | $130.53 | $130.88 | 686.7K |
| Sep 22, 2026 | $130.72 | $132.22 | $129.945 | $131.80 | 1.19M |
| Sep 21, 2026 | $130.00 | $130.87 | $128.96 | $129.79 | 922.16K |
| Sep 18, 2026 | $128.39 | $129.275 | $127.77 | $129.01 | 2.1M |
| Sep 17, 2026 | $129.10 | $129.82 | $128.36 | $128.46 | 1.21M |
The latest Smart Investors Daily articles mentioning DD.
Company
Market Activity
Research & News
DD research
Company profile and research snapshot.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 15, 2026 | RBC Capital | Outperform | — |
| Oct 13, 2026 | Barclays | Overweight | — |
| Oct 9, 2026 | JP Morgan | Neutral | — |
| Oct 7, 2026 | Citigroup | Buy | — |
| Oct 5, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Benzinga · Oct 9, 2026
JP Morgan analyst Chigusa Katoku downgrades DuPont de Nemours (NYSE:DD) from Overweight to Neutral and lowers the price target from $172 to $145.
Benzinga · Oct 7, 2026
Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $170 to $162.
Yahoo · Oct 6, 2026
JPMorgan analyst Jeffrey Zekauskas upgraded Corteva stock to Buy from Hold.
Yahoo · Oct 6, 2026
Nelipak’s Ecovate™ header bag, featuring all-polyethylene construction and Tyvek® with Renewable Attribution, recognized for helping the growing ready-to-fill/use market advance packaging circularity.CRANSTON, R.I., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak®”), a leading global provider of healthcare packaging solutions, announced it has been named a Dupont™ Tyvek® Sustainable Healthcare Packaging Awards winner in the Sustainability In-Use category for its innovative Ecova
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning DD.